We have located links that may give you full text access.
Effect of bariatric surgery on plasma GDF15 in humans.
American Journal of Physiology. Endocrinology and Metabolism 2019 Februrary 6
Bariatric surgery results in marked body weight loss and improves type 2 diabetes in most patients with obesity. The growth differentiation factor 15 (GDF15) has recently emerged as a novel satiety factor. To begin to understand whether GDF15 is involved in mediating the effects of bariatric surgery on body weight and glycaemia in humans, we measured plasma GDF15 in patients with obesity (n = 25) and in patients with obesity and diabetes (n = 22) before and after Roux-en-Y gastric bypass (RYGB) surgery. GDF15 was increased 1 week after RYGB compared with before surgery (689 ± 45 pg/ml vs. 487 ± 28 pg/ml, p<0.001) and GDF15 remained elevated at 3 months (554 ± 37 pg/ml, p<0.05), at 1 year (566 ± 37 pg/ml, p<0.05) and at 2.5-4 years (630 ± 50 pg/ml, p<0.001) after RYGB surgery. Both age and insulin sensitivity correlated with GDF15 before the surgery (r = 0.46, p<0.0001 and r = 0.34, p<0.001, respectively). These correlations disappeared at 2.5-4 years following the surgery. Conversely, weight loss magnitude correlated with GDF15, measured 2.5-4 years post-surgery (r = 0.21, p<0.0055). In summary, circulating GDF15 increases and correlates with body weight loss following RYGB surgery.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app